📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
Winner Medical Co Ltd
Winner Medical's GHG Emissions Data Preview
In 2024, Winner Medical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Winner Medical has also provided a category-level breakdown for 12 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
a
a
a
a
a
a
a
a
a
a
aVerified Sources Behind Winner Medical’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Winner Medical’s data sources below and access millions more through our Disclosure Search.
Insights into Winner Medical's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions ofWinner Medical amounted to213,229.1metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Winner Medicalincreased by 30.09%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
Winner Medical's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Winner Medical's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Winner Medical were 32,222.54 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Has Winner Medical reduced its Scope 1 emissions over time?
Since 2022, Winner Medical's Scope 1 emissions have decreased by 27.38%, reflecting a declining long-term trend in Scope 1 emissions over time.a
Compared to the previous year(2023), Winner Medical's Scope 1 emissions decreased by 13.35%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
What are Winner Medical's Scope 2 emissions?
In 2024, Winner Medical reported Scope 2 greenhouse gas (GHG) emissions of 181,006.56 tCOâ‚‚e without specifying the calculation method.a
Has Winner Medical reduced its Scope 2 emissions over time?
Since 2022, Winner Medical's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method)have increased by 28.41%, reflecting a rising long-term trend in Scope 2 emissions over time.a
Compared to the previous year(2023), Winner Medical's Scope 2 emissions(Unspecified Calculation Method) rose by 42.84% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya
What methodology does Winner Medical use for Scope 2 reporting?
In 2024, Winner Medical reported its Scope 2 emissions using an unspecified methodology.a
Winner Medical's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Winner Medical's Value Chain Emissions
In 2024, Winner Medical reported 1,014,392.14 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Winner Medical includes a breakdown across 12of the 15 Scope 3 categories defined by the GHG Protocol,up from 0 in 2023, reflecting improved emissions accounting practices and greater transparency across the company's value chaina
Winner Medical's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Winner Medical's Scope 3 emissions?
In 2024, Winner Medical reported total Scope 3 emissions of 1,014,392.14 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Approximately 90.73%of these emissions originated from upstream activities such as purchased goods and capital goods, while 9.27%came from downstream activities like product use, distribution, and end-of-life treatment.a
What categories of Scope 3 emissions does Winner Medical disclose?
In 2024, Winner Medical reported emissions for 12 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Winner Medical's Scope 3 emissions?
In 2024, the largest contributors to Winner Medical's Scope 3 emissions were:a
- Purchased Goods and Services (Cat. 1): 672,440.55 tCOâ‚‚e(66.3%)
- Upstream Transportation and Distribution (Cat. 4): 113,003.284 tCOâ‚‚e(11.14%)
- End-of-Life Treatment of Sold Products (Cat. 12): 86,223.332 tCOâ‚‚e(8.5%)
Winner Medical's Scope 3 Emissions by Categories
Insights into Winner Medical’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Winner Medical reported Scope 1 greenhouse gas (GHG) emissions of 32,222.54 tCOâ‚‚e and total revenues of USD 1,230 millions. This translates into an emissions intensity of 26.19 tCOâ‚‚e per millions USD.a
Winner Medical's Scope 1 Emissions Intensity Compared to Peers
How does Winner Medical's GHG emissions intensity compare to its peers?
In 2024, Winner Medical reported a Scope 1 emissions intensity of 26.19 tCOâ‚‚e per millions USD. Compared to the peer group median of 5.1, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
Where does Winner Medical rank on GHG emissions intensity within its industry?
In 2024, Winner Medical ranked 20 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
Winner Medical is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
Insights into Winner Medical's Total Carbon Footprint
In 2024, Winner Medical reported a total carbon footprint of 1,227,621.24 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 648.99% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Winner Medical's total carbon footprint was Scope 3 emissions, accounting for 82.63% of the company's total carbon footprint, followed by Scope 2 emissions at 14.74%.a